| __timestamp | AbbVie Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 7724000000 | 381287000 |
| Thursday, January 1, 2015 | 6387000000 | 452612000 |
| Friday, January 1, 2016 | 5855000000 | 316800000 |
| Sunday, January 1, 2017 | 6275000000 | 330100000 |
| Monday, January 1, 2018 | 7399000000 | 265800000 |
| Tuesday, January 1, 2019 | 6942000000 | 336200000 |
| Wednesday, January 1, 2020 | 11299000000 | 423900000 |
| Friday, January 1, 2021 | 12349000000 | 467000000 |
| Saturday, January 1, 2022 | 15260000000 | 487000000 |
| Sunday, January 1, 2023 | 12872000000 | 477100000 |
| Monday, January 1, 2024 | 14752000000 |
In pursuit of knowledge
In the ever-evolving pharmaceutical landscape, operational efficiency is paramount. Over the past decade, AbbVie Inc. and United Therapeutics Corporation have showcased contrasting strategies in managing Selling, General, and Administrative (SG&A) expenses. AbbVie, a global biopharmaceutical leader, has seen its SG&A expenses grow by approximately 66% from 2014 to 2023, peaking in 2022. This reflects its aggressive expansion and investment in marketing and administrative capabilities. In contrast, United Therapeutics, a pioneer in biotechnology, maintained a more stable SG&A trajectory, with a modest increase of around 28% over the same period. This stability underscores its focused approach in niche markets. As the industry faces mounting pressures, these insights into SG&A management offer a glimpse into the strategic priorities of these pharmaceutical giants.
Who Optimizes SG&A Costs Better? AbbVie Inc. or argenx SE
Selling, General, and Administrative Costs: AbbVie Inc. vs Biogen Inc.
AbbVie Inc. or Insmed Incorporated: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: AbbVie Inc. vs Grifols, S.A. Trends and Insights
AbbVie Inc. vs ImmunityBio, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: AbbVie Inc. vs Soleno Therapeutics, Inc.
Who Optimizes SG&A Costs Better? AbbVie Inc. or Mesoblast Limited
Breaking Down SG&A Expenses: United Therapeutics Corporation vs BioMarin Pharmaceutical Inc.
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Rhythm Pharmaceuticals, Inc.
United Therapeutics Corporation or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Selling, General, and Administrative Costs: United Therapeutics Corporation vs MiMedx Group, Inc.
Cost Management Insights: SG&A Expenses for United Therapeutics Corporation and Evotec SE